Vivek Jayaraman was named President and Chief Executive Officer of Cerus Corp, effective July 1, 2026. As of November 14, 2026, Cerus Corp has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from January 23, 2026 to July 10, 2026, naming 2 appointments and 1 departure (Form 8-K, March 16, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Cerus Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-07-10
- · In / out: In · Person: Vivek Jayaraman · Role: President and Chief Executive Officer · Effective: 2026-07-01 · 8-K, 2026-03-16
- · In / out: Out · Person: Timothy L. Moore · Role: Director · 8-K, 2026-01-23
Cerus Corp reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-01-23 to 2026-07-10. They name 2 people, with 2 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Cerus Corp files it.
Also on the record for Cerus Corp
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 13, 2026 | Stake report, Schedule 13G/A, by ARK Investment Management LLC | 10.18% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by ARK Investment Management LLC | 8.95% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Baker Bros. Advisors LP | 3.2% of the class | 5%+ stakes | Source |
| August 13, 2026 | Stake report, Schedule 13G/A, by Soleus Capital Master Fund, L.P. | 1.2% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| March 24, 2026 | Stake report, Schedule 13G, by Soleus Capital Master Fund, L.P. | 5.1% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Baker Bros. Advisors LP | 5.2% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by Julian C. Baker | 6.8% of the class | 5%+ stakes | Source |
| July 30, 2025 | Stake report, Schedule 13G/A, by ARK Investment Management LLC | 10.05% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Cerus Corp now and the warning signs.
Free to see. No signup.
Keep reading
More on Cerus Corp and the records around it.
Cerus Corp elsewhere on the record
- 5%+ stake filings Nov 2026
- Who owns it
Companies that share a holder
- ARK Investment Management LLC also filed stake reports on 23 other companies: Beam Therapeutics Inc. (Nov 2026), CRISPR Therapeutics AG (Nov 2026), GeneDx Holdings Corp. (Nov 2026)
- Soleus Capital Master Fund, L.P. also filed stake reports on 24 other companies: Beta Bionics, Inc. (Nov 2026), Evolus, Inc (Nov 2026), INSPIRE MEDICAL SYSTEMS, INC. (Nov 2026)
- Baker Bros. Advisors LP also filed stake reports on 25 other companies: Madrigal Pharmaceuticals, Inc. (Nov 2026), Kodiak Sciences Inc. (Sep 2026), BeOne Medicines Ltd. (Sep 2026)
Watch Cerus Corp
Get an email when Cerus Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Cerus Corp?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Cerus Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cerus Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-07-10 | Reported | not named in the filing | 8-K, 2026-07-10 | ||
| 2026-03-16 | In | President and Chief Executive Officer | 2026-07-01 | 8-K, 2026-03-16 | |
| 2026-03-16 | In | Chief Operating Officer | 8-K, 2026-03-16 | ||
| 2026-01-23 | Out | Director | 8-K, 2026-01-23 |
Why did they leave? What the filings say
For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- Timothy L. Moore, Director (filed 2026-01-23):
Mr. Moore's decision not to stand for re-election was not because of a disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Who leads Cerus Corp, as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- President and Chief Executive Officer: Vivek Jayaraman, appointed, effective 2026-07-01 (filed 2026-03-16).
- Chief Operating Officer: Vivek Jayaraman, appointed (filed 2026-03-16).
- Director: Timothy L. Moore, departure reported (filed 2026-01-23). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Cerus Corp: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the President and Chief Executive Officer at Cerus Corp, with the record behind each one.
Find candidates like President and Chief Executive Officer at Cerus CorpEvery change, in the filing's words
Reported
Pursuant to the Amendment, Mr. Greenman will serve as Executive Chairman (in which position it is anticipated that he will be able to perform his duties with a time commitment averaging about 60% of a full-time schedule) beginning on the Effective Date and ending on May 31, 2027, unless Mr. Greenman or the Company terminates his service earlier or Mr. Greenman and the Company extend his service by written agreement.
- As previously disclosed, William "Obi" Greenman, former President and Chief Executive Officer and Chairman of the Board of Directors (the "Board") of Cerus Corporation (the "Company"), ceased serving as President and Chief Executive Officer and began serving as Executive Chairman of the Board effective July 1, 2026 (the "Effective Date").
- On July 6, 2026, Mr. Greenman entered into an amendment (the "Amendment"), effective as of the Effective Date, to his existing Employment Letter Agreement, dated May 12, 2011, with the Company (as amended December 5, 2012 and April 17, 2018, the "Letter Agreement") setting forth the initial terms of his service as Executive Chairman.
- For his service as Executive Chairman, Mr. Greenman will receive an annual base salary of $500,000 and, for 2026, will be eligible to earn an annual cash bonus, with a target annual cash bonus opportunity of 80% of his total base salary earned in 2026.
- Pursuant to the Amendment, Mr. Greenman will not be entitled to earn an annual cash bonus for any portion of 2027.
Appointed: Vivek Jayaraman, President and Chief Executive Officer, effective 2026-07-01
On March 16, 2026, Cerus Corporation (the "Company") announced that Vivek Jayaraman, the Company's Chief Operating Officer, will be appointed as the Company's President and Chief Executive Officer, effective July 1, 2026 (the "Effective Date").
Appointed: Vivek Jayaraman, Chief Operating Officer
Mr. Jayaraman, 52, was appointed as the Company's Chief Operating Officer in March 2020.
- Effective on the same date, William "Obi" Greenman, the Company's President and Chief Executive Officer and Chairman of the Company's Board of Directors (the "Board"), will cease serving as President and Chief Executive Officer and will serve as Executive Chairman of the Board.
- Mr. Jayaraman will also be appointed to the Board, effective on the Effective Date.
- He previously served as the Company's Chief Commercial Officer since August 2016.
- From October 2009 to February 2016, Mr. Jayaraman served as Vice President, Sales and Marketing of TriVascular Technologies, Inc., or TriVascular, where he oversaw TriVascular's commercial expansion as the company grew from a preclinical, venture-backed startup into a publicly traded, global medical device company.
- Prior to TriVascular, Mr. Jayaraman served in roles of increasing responsibility at Medtronic, Inc.; most recently serving as vice president of global marketing for Medtronic's endovascular innovations business.
- Mr. Jayaraman received his MBA from the Wharton School at the University of Pennsylvania and holds dual bachelor's degrees from the University of Michigan.
Departing: Timothy L. Moore, Director
On January 19, 2026, Timothy L. Moore, a member of the class of directors whose terms of office expire at the 2026 annual meeting of stockholders (the "2026 Annual Meeting") of Cerus Corporation (the "Company"), informed the Company that he would not stand for re-election at the 2026 Annual Meeting.
Tools for this story
Each opens in a new tab, filled in for Cerus Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
